Skip to main content

Table 3 Prevalence of symptoms and risk factors and their association with HIV-1 seroconversiona

From: Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men

Column 1

2

3

4

5

6

7

8

Symptom

Seroconversion visit

n%

HIV negative visit

n%

OR

(95% CI)

Symptom based model aOR

(95% CI)b

Beta coefficientc,d

Combined model aOR (95% CI)e

Beta coefficientc,f

Totalg

175

17,271

     

Symptom

 Diarrhea

30

17.1

1011

5.9

3.3 (2.2–4.8)

1.3 (0.8–2.1)

0.3

1.5 (0.9–2.4)

0.4

 Fatigue

42

24.0

1867

10.8

2.6 (1.8–3.6)

1.2 (0.8–1.9)

0.2

1.4 (0.9–2.2)

0.3

 Fever

76

43.4

1623

9.4

7.2 (5.4–9.8)

5.0 (3.5–7.1)h

1.6

4.7 (3.2–7.0)h

1.6

 Genital ulcers

11

6.3

324

1.9

3.5 (1.9–6.4)

2.6 (1.3–5.0)h

0.9

1.6 (0.6–4.0)

0.5

 Headache

18

10.3

980

5.7

1.9 (1.2–3.1)

0.7 (0.4–1.3)

−0.3

0.8 (0.4–1.5)

−0.2

 Lymphadenopathy

27

15.4

418

2.4

7.2 (4.7–10.9)

3.3 (2.1–5.4)h

1.2

4.4 (2.6–7.3)h

1.5

 Myalgia

25

14.3

869

5.0

3.1 (2.0–4.7)

1.1 (0.7–1.9)

0.1

1.4 (0.8–2.4)

0.3

 Nausea

18

10.3

526

3.1

3.6 (2.2–5.8)

0.8 (0.4–1.7)

−0.2

0.9 (0.4–1.9)

−0.1

 Night sweats

32

18.3

832

4.8

4.3 (3.0–6.4)

1.2 (0.8–2.0)

0.2

1.2 (0.7–2.1)

0.2

 Oral thrush

4

2.3

36

0.2

10.8 (3.8–30.7)

5.0 (1.5–16.3)h

1.6

5.6 (1.4–22.3)h

1.7

 Rash

11

6.3

564

3.3

2.0 (1.1–3.6)

1.2 (0.6–2.4)

0.2

0.6 (0.3–1.4)

−0.5

 Sore throat

31

17.7

1316

7.6

2.6 (1.7–3.8)

1.0 (0.7–1.6)

0.0

0.9 (0.5–1.4)

−0.2

 Vomiting

17

9.7

336

2.0

5.3 (3.2–8.8)

1.8 (0.9–3.8)

0.6

1.4 (0.6–3.3)

0.4

 Weight loss

11

6.3

205

1.2

5.5 (2.9–10.2)

1.9 (1.0–3.9)

0.7

2.4 (1.1–5.2)h

0.9

Risk factor

 Gonorrheai,j

12

6.9

181

1.1

6.5 (3.6–12.0)

  

4.9 (2.3–10.2)h

1.6

 Receptive CLAIi

97

55.4

5651

32.7

2.7 (2.0–3.7)

  

3.0 (2.1–4.2)h

1.1

 >5 sexual partnersi,k

100

57.1

7659

44.4

2.4 (1.7–3.4)

  

2.5 (1.7–3.6)h

0.9

  1. aOR adjusted odds ratio. CI confidence interval, CLAI condomless anal intercourse, OR odds ratio
  2. aIn Amsterdam Cohort Studies, based on imputed data using the last observation carried forward method
  3. b14 symptoms in column 1 were included in a multivariable logistic regression model using generalized estimating equations
  4. cNatural log of the adjusted odds ratio, rounded to one decimal
  5. dBased on the adjusted odds ratios of the symptom-based model (column 5)
  6. e14 symptoms and 3 risk factors in column 1 were included in a multivariable logistic regression model using generalized estimating equations
  7. fBased on the adjusted odds ratios of the combined symptom and risk factor model (column 7)
  8. gDue to missing values, the denominator of columns 2 and 3 are sometimes not equal to 175 respectively 17,271. Data missing for the following variables: fever, 1 missing; genital ulcers, 3 missings; gonorrhea, 2072 missings; receptive condomless anal intercourse, 162 missings; >5 sexual partners, 56 missings
  9. hSignificantly associated with HIV-1 seroconversion
  10. iIn the preceding 6 months
  11. jSelf-reported
  12. kOnly male sex partners, compared to ≤5 sexual partners